Article Details
Retrieved on: 2024-11-27 13:06:01
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article outlines Radiopharm Theranostics' strategic biotech advancement as it lists its American Depositary Shares on NASDAQ under the ticker RADX. This move expands its market presence, particularly due to significant U.S. investor interest, without raising additional capital. The listing involves a cross-listing setup facilitated by depositary receipts.
Article found on: www.stocktitan.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here